Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Multi

DKB Fonds - Pharma Fonds

+ Add to Watchlist

DKEB:GR

61.2400 EUR 0.1000 0.16%

As of 11:42:03 ET on 05/04/2015.

Snapshot for DKB Fonds - Pharma Fonds (DKEB)

Open: 61.7200 High - Low: 62.6000 - 60.7900 Primary Exchange: Berlin
Volume: 393 52-Week Range: 40.4800 - 65.5400 Beta vs MSGUHC: 0.9685

ETF Chart for DKEB

No chart data available.
  • DKEB:GR 62.6000
  • 1D
  • 1M
  • 1Y
61.3400
Interactive DKEB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DKEB

DKB Pharma Fonds is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term growth. The Fund invests in equities issued by pharmaceutical, technology and biotechnology companies in North America and Europe.

Inception Date: 2000-08-30 Telephone: 352-424345464
Managers: MARKUS HAMELLA
Web Site: www.bayerninvest.lu

Fundamentals for DKEB

NAV (on 2015-05-04) 60.9300
Assets (M) (on 2015-05-04) 47.3048
Shares out (M) 0.62
Market Cap (M) 37.94
% Premium 0.51
Average 52-Week % Premium -0.5095
Fund Leveraged N

Dividends for DKEB

No dividends reported

Performance for DKEB

1-Month -1.62% 1-Year +48.89%
3-Month +8.89% 3-Year +28.18%
Year To Date +17.36% 5-Year +19.07%
Expense Ratio 2.51

Top Fund Holdings for DKEB

Filing Date: 03/31/2015
Name Position Value % of Total
Novartis AG 31,933 2,987,266 6.012%
Pfizer Inc 85,500 2,760,914 5.556%
Roche Holding AG 7,850 1,988,790 4.002%
Merck & Co Inc 34,000 1,830,055 3.683%
Sanofi 18,000 1,668,600 3.358%
Gilead Sciences Inc 17,100 1,588,551 3.197%
Amgen Inc 9,600 1,455,261 2.929%
UnitedHealth Group Inc 11,800 1,317,305 2.651%
GlaxoSmithKline PLC 57,000 1,232,460 2.480%
Medtronic PLC 16,797 1,215,283 2.446%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil